Johan Maertens Selected Research

glasdegib

8/2022

A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes.

1/2022

Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johan Maertens Research Topics

Disease

45	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 01/2007
45	Aspergillosis 02/2024 - 11/2002
43	Infections 04/2024 - 01/2005
42	Neoplasms (Cancer) 05/2024 - 09/2004
33	Leukemia 04/2024 - 10/2003
31	Mycoses (Diseases, Fungus) 04/2024 - 09/2005
26	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024 - 10/2003
21	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 01/2007
16	Neutropenia 02/2024 - 01/2006
15	Invasive Fungal Infections 12/2021 - 09/2005
14	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 06/2005
13	Communicable Diseases (Infectious Diseases) 04/2024 - 11/2006
11	COVID-19 12/2023 - 12/2021
11	Invasive Pulmonary Aspergillosis 01/2022 - 12/2009
10	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 12/2004
8	Fever (Fevers) 01/2023 - 09/2005
5	Cytomegalovirus Infections (Inclusion Disease) 11/2023 - 04/2011
5	Pulmonary Aspergillosis 09/2023 - 12/2004
5	Critical Illness (Critically Ill) 10/2022 - 11/2011
5	Febrile Neutropenia 01/2022 - 06/2006
5	Hematologic Diseases (Blood Diseases) 12/2021 - 12/2009
4	Mucositis 01/2024 - 03/2008
4	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 01/2019
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2021 - 06/2005
4	Refractory Anemia 01/2020 - 09/2009
4	Multiple Myeloma 11/2019 - 10/2003
3	Lymphopenia (Lymphocytopenia) 04/2024 - 07/2023
3	Pneumonia (Pneumonitis) 02/2024 - 04/2009
3	Viremia 11/2023 - 01/2019
3	Body Weight (Weight, Body) 11/2023 - 03/2008
3	Stomatitis 05/2023 - 03/2008
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2023 - 11/2013
3	Toxoplasmosis 03/2022 - 01/2005
3	Lymphoma (Lymphomas) 12/2021 - 07/2003
3	Mucormycosis 06/2020 - 01/2017
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 10/2014
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 09/2005
3	Bronchiolitis Obliterans Syndrome 01/2019 - 01/2018
2	Nocardia Infections 04/2024 - 01/2022
2	Inflammation (Inflammations) 02/2024 - 01/2022
2	Respiratory Insufficiency (Respiratory Failure) 12/2023 - 01/2021
2	Cytopenia 01/2023 - 08/2009
2	Virus Diseases (Viral Diseases) 01/2023 - 10/2021

Drug/Important Bio-Agent (IBA)

23	galactomannanIBA 10/2023 - 11/2002
11	Voriconazole (Vfend)FDA LinkGeneric 10/2021 - 04/2009
10	Caspofungin (Cancidas)FDA Link 01/2023 - 06/2003
9	posaconazole FDA Link 10/2021 - 01/2007
9	Sodium Glutamate (Accent)IBA 01/2019 - 06/2008
8	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2009
7	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 01/2016
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 01/2016
7	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 04/2008
7	liposomal amphotericin B FDA Link 10/2022 - 05/2007
7	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2005
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 09/2005
6	Phosphotransferases (Kinase)IBA 01/2022 - 06/2005
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 07/2015
4	ruxolitinibIBA 04/2024 - 12/2019
4	AntigensIBA 04/2024 - 04/2009
4	maribavirIBA 11/2023 - 04/2011
4	TriazolesIBA 01/2023 - 12/2006
4	AzolesIBA 01/2023 - 07/2015
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 12/2019
4	SteroidsIBA 01/2023 - 11/2002
4	polyglucosanIBA 01/2021 - 11/2011
4	letermovirIBA 10/2020 - 12/2017
4	EnzymesIBA 01/2016 - 09/2004
3	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2024 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2020
3	Valganciclovir FDA Link 11/2023 - 01/2019
3	Melphalan (Alkeran)FDA LinkGeneric 11/2023 - 03/2008
3	Fluconazole (Zonal)FDA LinkGeneric 01/2023 - 01/2007
3	fludarabineIBA 01/2023 - 01/2016
3	EchinocandinsIBA 11/2013 - 12/2006
3	Itraconazole (Sporanox)FDA LinkGeneric 04/2007 - 09/2005
2	venetoclaxIBA 04/2024 - 01/2022
2	midostaurinIBA 04/2024 - 01/2022
2	Immunosuppressive Agents (Immunosuppressants)IBA 02/2024 - 01/2023
2	Interleukin-17 (Interleukin 17)IBA 02/2024 - 05/2010
2	VaccinesIBA 12/2023 - 08/2015
2	Busulfan (Busulfex)FDA Link 11/2023 - 01/2021
2	23-valent pneumococcal capsular polysaccharide vaccineIBA 10/2023 - 08/2015
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2022
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2023 - 01/2021
2	Monoclonal AntibodiesIBA 01/2023 - 01/2022
2	glasdegibIBA 08/2022 - 01/2022
2	Cefepime (Maxipime)FDA LinkGeneric 01/2022 - 11/2020

Therapy/Procedure

60	Therapeutics 04/2024 - 12/2004
53	Transplantation 05/2024 - 12/2004
40	Stem Cell Transplantation 01/2024 - 07/2003
39	Hematopoietic Stem Cell Transplantation 04/2024 - 11/2006
25	Cell Transplantation 04/2024 - 05/2012
24	Drug Therapy (Chemotherapy) 11/2023 - 07/2003
6	Homologous Transplantation 10/2023 - 10/2003
4	Salvage Therapy 07/2020 - 06/2006
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2020 - 01/2016
3	Organ Transplantation 01/2019 - 12/2004
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2018 - 12/2011
2	Central Venous Catheters 01/2024 - 11/2020
2	Biological Therapy 05/2022 - 01/2022